We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Targetable Vulnerability in Breast Cancer Cells

News   Mar 31, 2019 | Original story from University of Helsinki

 
A Targetable Vulnerability in Breast Cancer Cells

New study reveals that FGFR4 phosphorylates the essential proteins (MST1/2) of Hippo tumor suppressor pathway preventing their activation and induction of programmed cell death in breast cancer cells. Cell death program can be reactivated by blocking FGFR4 function with a specific inhibitor. These findings suggest new options for eradicating cancer cells with excessive FGFR4 expression. Credit: M Varjosalo & Lehti Group

 
 
Advertisement
 

RELATED ARTICLES

Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions

News

A study has found that delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions.

READ MORE

Mass-Farming of Kelp, Maggots and Mycoprotein Essential To Combat Malnutrition

News

Researchers suggest state-of-the-art, controlled-environment systems, producing novel foods can reduce vulnerability to environmental changes, pests and diseases.

READ MORE

Skin-Patch Vaccine for Dengue Fever Successful in Preclinical Models

News

A dengue virus vaccine candidate has shown promising results in animal models, producing a protective immune response in dengue-infected mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE